Tag

Ebt 101

All articles tagged with #ebt 101

science-and-technology2 years ago

CRISPR's Potential: A Cure for HIV?

Researchers are conducting a clinical trial to test the safety of a new gene therapy called EBT-101, which uses CRISPR-Cas9 gene editing to potentially cure HIV. This is the first time a gene-editing treatment for HIV has been tried in humans. While initial results show no toxic effects or serious adverse events, it is still unknown if EBT-101 can effectively target latent HIV cells and control the virus in humans. The trial will continue to test additional doses of EBT-101 for safety and determine if the virus remains suppressed when patients are taken off current HIV treatments. Long-term follow-up studies will be conducted to assess any potential adverse effects.

health2 years ago

Assessing the Safety and Potential of CRISPR Gene Therapy for HIV/AIDS Cure

A CRISPR-based gene therapy called EBT-101 has shown no serious adverse effects in the first three participants of a clinical trial. The therapy aims to remove HIV genomes from CD4 cells using CRISPR/Cas9 technology. While initial results are promising, it is premature to claim a cure for HIV. Further data is needed to determine if EBT-101 can delay HIV rebound or maintain viral suppression. The therapy still needs to be tested in more people, assessed for long-term side effects, gain regulatory approval, and address affordability concerns.

health2 years ago

CRISPR Gene Editing: A Potential Cure for HIV and PFAS Destruction

Three patients have received CRISPR gene-editing therapies in an effort to eradicate HIV from their bodies. The potential treatment, called EBT-101, is safe and has caused no major side effects. Six more men will be treated with higher doses, and data will be presented at a medical conference next year. The therapy aims to permanently remove viral DNA without cutting human DNA. While there have been promising results in animals, success in humans is still uncertain. A cure for HIV is needed to end the pandemic, and Excision BioTherapeutics' therapy could potentially be a lifelong cure.